Across the world, populations are ageing at an unprecedented rate. By 2050, it is estimated that over 2.1 billion people will be over 60 years old, with nearly 400 million suffering from osteoporosis. Often called the “silent disease,” osteoporosis progresses unnoticed until a sudden fracture changes everything, robbing individuals of mobility, independence, and quality of life.
Current treatments, such as bisphosphonate drugs and hormone therapies, aim to slow bone loss but do not truly restore the bone’s natural ability to rebuild. These therapies often require long-term use and can cause unwanted side effects, including digestive problems and, paradoxically, a higher risk of rare fractures. There is an urgent need for treatments that move beyond managing symptoms to actively repairing ageing bones.
The overlooked power of bone stem cells
At the heart of bone health are bone marrow mesenchymal stem cells (BMSCs), responsible for maintaining and repairing bone tissue throughout life. In young individuals, these cells are highly active, capable of multiplying and creating new bones. However, with age, BMSCs lose their vitality. They slow down, struggle to divide, and are less able to generate fresh bone tissue.
The loss of BMSC function is a major factor behind the decline in bone health with age. Yet scientists have recently discovered that the key to restoring these essential cells may lie in an often-overlooked part of the cell: the Golgi apparatus. A recent study explores the importance of these organelles in bone ageing.
The Golgi apparatus: An unexpected gatekeeper of youth
Discovered in 1898 by the Italian scientist Camillo Golgi, the Golgi apparatus acts as the cell’s post office. It processes, packages, and dispatches proteins to where they are needed. In young, healthy cells, the Golgi appears as a neatly stacked series of membranes. In aged cells, however, this structure collapses into a tangled mess.
Researchers used a chemical called Brefeldin A (BFA) to deliberately disrupt the Golgi in young cells. The results were immediate and dramatic. Cells treated with BFA displayed all the classic signs of ageing: they stopped dividing, lost their ability to build bone, and entered a state known as cellular senescence. This experiment confirmed that a broken Golgi is not just a symptom of ageing but a direct cause.
Tiny messengers with a big impact
The next question was how to repair the damaged Golgi in ageing cells. The answer came from an unexpected source: extracellular vesicles (EVs) released by stem cell aggregates (Figure 1). Stem cell aggregates are clusters of stem cells that mimic the conditions of early embryonic development, creating a highly regenerative environment.
These aggregates secrete EVs packed with proteins, lipids, and other molecules essential for cellular repair. Importantly, EVs from stem cell aggregates (CA-EVs) were found to be rich in Golgi-related proteins, particularly Syntaxin 5 (STX5), a protein crucial for rebuilding the Golgi structure.
When scientists treated ageing BMSCs with CA-EVs, the results were striking. The Golgi apparatus in old cells regained its youthful organised structure. Even more promising, the cells themselves began to multiply and rebuild bone tissue once again, as if they had turned back the clock.
Credit. Authors
From laboratory success to potential therapies
The true test of any medical breakthrough lies in living organisms. In experiments with ageing mice, researchers observed remarkable effects when CA-EVs were introduced. Bone defects healed faster, with greater bone volume and strength compared to those treated with traditional stem cell transplants. More astonishingly, regular infusions of CA-EVs increased bone mass and density, reversing signs of osteoporosis in older mice.
This research opens the door to a new generation of treatments that do not just slow bone loss but actively restore the body’s natural regenerative processes. By targeting the Golgi apparatus, therapies could rejuvenate the ageing cells themselves, offering safer and more effective solutions than current medications.
A glimpse into the future of regenerative medicine
While these findings are undeniably exciting, many questions remain before Golgi-focused therapies can become a reality for patients. One major challenge is understanding how inflammatory factors in ageing tissues might influence the ability of EVs to repair the Golgi. Ageing is often accompanied by chronic low-grade inflammation, which could potentially interfere with the healing process.
Researchers are also exploring whether CA-EVs might have benefits beyond bone tissue. Early hints suggest they could help rejuvenate other organs, such as the liver and lungs, by repairing damaged Golgi structures. If proven, this would represent a major advance in regenerative medicine, offering treatments that could delay or even reverse multiple aspects of ageing.
Another technical hurdle is delivering CA-EVs efficiently and specifically to the right tissues. Engineering vesicles with targeting molecules could help ensure they reach bone tissues with maximum impact and minimal side effects.
Transforming the landscape of ageing
The implications of Golgi restoration extend far beyond osteoporosis. By addressing a fundamental cause of cellular ageing, scientists may be laying the foundation for therapies that preserve health, vitality, and independence well into old age.
Rather than viewing ageing as an inevitable decline, this research invites a new perspective: ageing could become something to be managed, slowed, and even reversed at the cellular level. Healthy bones are not just important for movement but also play vital roles in mineral storage, immune function, and hormone production. Strengthening them could ripple through the entire body, enhancing overall health.
Hope on the horizon
Although much work remains, including clinical trials and further exploration of long-term safety, the discovery of Golgi restoration is a hopeful step. It shows that even in the smallest structures of our cells, there lies a capacity for renewal.
The future may hold treatments where ageing cells are simply “rebooted,” regaining their youthful abilities without the need for invasive surgeries or long-term medications. A healthier, more resilient old age may no longer be a distant dream but a tangible reality.
Conclusion: Are we ready to change how we think about ageing?
The discovery that repairing the Golgi apparatus can rejuvenate ageing bone cells is a remarkable leap forward. It offers not just a potential cure for osteoporosis but a glimpse into a new era of regenerative medicine.
As research progresses, the question for all of us becomes: are we prepared to rethink ageing itself? If scientists can unlock the mechanisms of cellular youth, the possibilities for future generations could be greater than ever imagined. The journey has begun, and the future of healthy ageing may be closer than we think.
🔬🧫🧪🔍🤓👩🔬🦠🔭📚
Journal reference
Liu, P., Guo, H., Huang, X., Liu, A., Zhu, T., Zheng, C., … & Sui, B. (2025). Golgi-restored vesicular replenishment retards bone aging and empowers aging bone regeneration. Bone Research, 13(1), 21. 10.1038/s41413-024-00386-w.
